SEC INSIDER TRANSACTIONS

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

CRL · CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 36 filings · fetched 2026-11-13T17:01:24Z

Recent reported activity

1purchase rows on this page

7sale rows on this page

100matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-11-06Filed 2026-11-09	Knell Michael GunnarOfficer · SVP, Finance and CAO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units. Exhibit 24 - Power of Attorney References: F1	F WithholdingCommon Stock · Non-derivative	649D	313.02	Direct	Form 4 ↗0001100682-26-000159
2026-10-22Filed 2026-10-26	FOSTER JAMES CDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 6, 2026. Exhibit 24 - Power of Attorney References:	M Exercise / conversionStock Options (Right to Buy) · Derivative	24,042D	0	Direct	Form 4 ↗0001100682-26-000153
2026-10-22Filed 2026-10-26	FOSTER JAMES CDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 6, 2026. Exhibit 24 - Power of Attorney References: F1	S Sale (market/private)Common Stock · Non-derivative	24,042D	350	Direct	Form 4 ↗0001100682-26-000153
2026-10-22Filed 2026-10-26	FOSTER JAMES CDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 6, 2026. Exhibit 24 - Power of Attorney References:	M Exercise / conversionCommon Stock · Non-derivative	24,042A	244.41	Direct	Form 4 ↗0001100682-26-000153
2026-10-21Filed 2026-10-23	Parisotto Shannon MOfficer · CEVP, Disc & Safety Assessment Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 4, 2026. References:	M Exercise / conversionStock Options (Right to Buy) · Derivative	2,156D	0	Direct	Form 4 ↗0001100682-26-000151
2026-10-21Filed 2026-10-23	Parisotto Shannon MOfficer · CEVP, Disc & Safety Assessment Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 4, 2026. References: F1	S Sale (market/private)Common Stock · Non-derivative	2,156D	344.41	Direct	Form 4 ↗0001100682-26-000151
2026-10-21Filed 2026-10-23	Parisotto Shannon MOfficer · CEVP, Disc & Safety Assessment Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 4, 2026. References:	M Exercise / conversionCommon Stock · Non-derivative	2,156A	244.41	Direct	Form 4 ↗0001100682-26-000151
2026-10-05Filed 2026-10-07	Parisotto Shannon MOfficer · CEVP, Disc & Safety Assessment Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was adopted on March 4, 2026. References:	M Exercise / conversionStock Options (Right to Buy) · Derivative	981D	0	Direct	Form 4 ↗0001952784-26-000003
2026-10-05Filed 2026-10-07	Parisotto Shannon MOfficer · CEVP, Disc & Safety Assessment Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was adopted on March 4, 2026. References: F1	S Sale (market/private)Common Stock · Non-derivative	981D	308.44	Direct	Form 4 ↗0001952784-26-000003
2026-10-05Filed 2026-10-07	Parisotto Shannon MOfficer · CEVP, Disc & Safety Assessment Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was adopted on March 4, 2026. References:	M Exercise / conversionCommon Stock · Non-derivative	981A	208.44	Direct	Form 4 ↗0001952784-26-000003
2026-09-30Filed 2026-10-02	Coleman GlennOfficer · EVP & Chief Financial Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The shares were acquired pursuant to the Company's Employee Stock Purchase Plan at the fair market value of the Company's common stock on the purchase date. The Reporting Person elected to participate in the Plan during an open trading window prior to the commencement of the quarterly purchase period. References: F1	P Purchase (market/private)Common Stock · Non-derivative	10A	297.43	Direct	Form 4 ↗0001100682-26-000144
2026-08-25Filed 2026-08-27	FOSTER JAMES CDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 6, 2026. References:	M Exercise / conversionStock Options (Right to Buy) · Derivative	12,429D	0	Direct	Form 4 ↗0001100682-26-000140
2026-08-25Filed 2026-08-27	FOSTER JAMES CDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 6, 2026. References:	M Exercise / conversionStock Options (Right to Buy) · Derivative	21,132D	0	Direct	Form 4 ↗0001100682-26-000140
2026-08-25Filed 2026-08-27	FOSTER JAMES CDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 6, 2026. References: F1	S Sale (market/private)Common Stock · Non-derivative	33,561D	300	Direct	Form 4 ↗0001100682-26-000140
2026-08-25Filed 2026-08-27	FOSTER JAMES CDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 6, 2026. References:	M Exercise / conversionCommon Stock · Non-derivative	12,429A	208.44	Direct	Form 4 ↗0001100682-26-000140
2026-08-25Filed 2026-08-27	FOSTER JAMES CDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 6, 2026. References:	M Exercise / conversionCommon Stock · Non-derivative	21,132A	194.12	Direct	Form 4 ↗0001100682-26-000140
2026-08-19Filed 2026-08-20	Girshick BirgitDirector · Officer · Chief Executive Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	G GiftCommon Stock · Non-derivative	528D	0	Direct	Form 4 ↗0001100682-26-000138
2026-08-19Filed 2026-08-20	Parisotto Shannon MOfficer · CEVP, Disc & Safety Assessment Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 4, 2026. References:	M Exercise / conversionStock Options (Right to Buy) · Derivative	2,039D	0	Direct	Form 4 ↗0001100682-26-000136
2026-08-19Filed 2026-08-20	Parisotto Shannon MOfficer · CEVP, Disc & Safety Assessment Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 4, 2026. References: F1	S Sale (market/private)Common Stock · Non-derivative	2,039D	294.12	Direct	Form 4 ↗0001100682-26-000136
2026-08-19Filed 2026-08-20	Parisotto Shannon MOfficer · CEVP, Disc & Safety Assessment Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 4, 2026. References:	M Exercise / conversionCommon Stock · Non-derivative	2,039A	194.12	Direct	Form 4 ↗0001100682-26-000136
2026-08-18Filed 2026-08-20	Andrews Nancy CDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	M Exercise / conversionStock Options (Right to Buy) · Derivative	573D	0	Direct	Form 4 ↗0001100682-26-000134
2026-08-18Filed 2026-08-20	Andrews Nancy CDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	S Sale (market/private)Common Stock · Non-derivative	573D	285.24	Direct	Form 4 ↗0001100682-26-000134
2026-08-18Filed 2026-08-20	Andrews Nancy CDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	M Exercise / conversionCommon Stock · Non-derivative	573A	164.3	Direct	Form 4 ↗0001100682-26-000134
2026-08-11Filed 2026-08-13	Girshick BirgitDirector · Officer · Chief Executive Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 3, 2025. References:	M Exercise / conversionStock Options (Right to Buy) · Derivative	6,500D	0	Direct	Form 4 ↗0001100682-26-000132
2026-08-11Filed 2026-08-13	Girshick BirgitDirector · Officer · Chief Executive Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 3, 2025. References: F1	S Sale (market/private)Common Stock · Non-derivative	6,500D	279.9	Direct	Form 4 ↗0001100682-26-000132

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.